Replying to an earlier post

When companies are not able to produce enough to satisfy demand and are actively stopping selling to certain sectors and harming them, they should lose their patents. RAM companies are actively harming all of us by selling their products to the AI companies and leaving us all without RAM, so we should encourage alternatives.

en

Replying to an earlier post

It is. It’s called Compulsory Licensing.

There is also an FDA Shortage list (most countries have a similar list).
A drug on that list gives the government additional powers to allow companies to work around the parents.

I think this is why there has been so many “off-brand” weight loss drugs recently. Novo Nordisk had supply chain issues with semaglutide, triggering governments to allow other manufacturers

Replying to an earlier post

Oh look, 'Murica brain…
It’s a common thing in a lot of the world. I’ve been on many medications throughout the years and all of them have had several options at each of the several drug store companies, and the default is always the cheapest. They always ask “are you ok with another brand?” if there’s a cheaper one than the one written on the prescription.

Replying to an earlier post

When companies are not able to produce enough to satisfy demand and are actively stopping selling to certain sectors and harming them, they should lose their patents.

Except they stop selling to certain sectors because these sectors pay less. I am pretty sure that if a laptop maker ask to buy the RAM at a 50% higher price than AI companies, the RAM producer will happily sell to them.

RAM companies are actively harming all of us by selling their products to the AI companies and leaving us all without RAM, so we should encourage alternatives.

And how do you plan to keep these alternatives from selling to the higher bidder, which will probably be a AI company ?